162 related articles for article (PubMed ID: 38057092)
1. Synergistic Interaction of Thyroid Autoantibodies and Ring Finger Protein 213 Variant in Moyamoya Disease.
Thamamongood T; Hara S; Akagawa H; Inaji M; Tanaka Y; Nariai T; Maehara T
Neurol Med Chir (Tokyo); 2024 Jan; 64(1):43-49. PubMed ID: 38057092
[TBL] [Abstract][Full Text] [Related]
2. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance.
Zhang Q; Liu Y; Zhang D; Wang R; Zhang Y; Wang S; Yu L; Lu C; Liu F; Zhou J; Zhang X; Zhao J
J Neurosurg; 2017 Apr; 126(4):1106-1113. PubMed ID: 27128593
[TBL] [Abstract][Full Text] [Related]
3. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
[TBL] [Abstract][Full Text] [Related]
4.
Ok T; Jung YH; Kim J; Park SK; Park G; Lee S; Lee KY
J Am Heart Assoc; 2022 Aug; 11(15):e025676. PubMed ID: 35876407
[TBL] [Abstract][Full Text] [Related]
5. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.
Liao X; Deng J; Dai W; Zhang T; Yan J
Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161
[TBL] [Abstract][Full Text] [Related]
6. Absence of the RNF213 p.R4810K variant may indicate a severe form of pediatric moyamoya disease in Japanese patients.
Hara S; Mukawa M; Akagawa H; Thamamongood T; Inaji M; Tanaka Y; Maehara T; Kasuya H; Nariai T
J Neurosurg Pediatr; 2022 Jan; 29(1):48-56. PubMed ID: 34624841
[TBL] [Abstract][Full Text] [Related]
7. Renovascular hypertension and
Kim JY; Cho H
Clin Nephrol; 2021 Aug; 96(2):105-111. PubMed ID: 33769276
[TBL] [Abstract][Full Text] [Related]
8. RNF213 p.R4810K Polymorphism and the Risk of Moyamoya Disease, Intracranial Major Artery Stenosis/Occlusion, and Quasi-Moyamoya Disease: A Meta-Analysis.
Wang Y; Mambiya M; Li Q; Yang L; Jia H; Han Y; Liu W
J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2259-2270. PubMed ID: 29752070
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of genotype and phenotype studies to confirm the predictive role of the RNF213 p.R4810K variant for moyamoya disease.
Wang Y; Yang L; Wang X; Zeng F; Zhang K; Zhang Q; Liu M; Liu S; Shang M; Li Q; Yang Y; Liang M; Liu W
Eur J Neurol; 2021 Mar; 28(3):823-836. PubMed ID: 33175469
[TBL] [Abstract][Full Text] [Related]
10. The Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease and a Review of the Pertinent Literature.
Zhang Q; Liu Y; Yu L; Duan R; Ma Y; Ge P; Zhang D; Zhang Y; Wang R; Wang S; Zhao Y; Cao Y; Liu X; Deng X; Zhao J; Zhang X
World Neurosurg; 2017 Mar; 99():701-708.e1. PubMed ID: 28063898
[TBL] [Abstract][Full Text] [Related]
11. Role of the
Kim HJ; Choi EH; Chung JW; Kim JH; Kim YS; Seo WK; Kim GM; Bang OY
J Am Heart Assoc; 2021 Jan; 10(1):e017660. PubMed ID: 33356381
[TBL] [Abstract][Full Text] [Related]
12. Development of atherosclerotic-moyamoya syndrome with genetic variant of RNF213 p.R4810K and p.T1727M: A case report.
Liu Y; Wu X; Fan Z; Cheng J; Zhong L; Lin Y; Qu X
Clin Neurol Neurosurg; 2018 May; 168():163-166. PubMed ID: 29567577
[TBL] [Abstract][Full Text] [Related]
13. Predictive role of heterozygous p.R4810K of
Wang Y; Zhang Z; Wei L; Zhang Q; Zou Z; Yang L; Li D; Shang M; Han C; Mambiya M; Bao X; Li Q; Hao F; Zhang K; Wang H; Liu S; Liu M; Zeng F; Nie F; Wang K; Liu W; Duan L
Neurology; 2020 Feb; 94(7):e678-e686. PubMed ID: 31949090
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population.
Wu Z; Jiang H; Zhang L; Xu X; Zhang X; Kang Z; Song D; Zhang J; Guan M; Gu Y
PLoS One; 2012; 7(10):e48179. PubMed ID: 23110205
[TBL] [Abstract][Full Text] [Related]
15. A new horizon of moyamoya disease and associated health risks explored through RNF213.
Koizumi A; Kobayashi H; Hitomi T; Harada KH; Habu T; Youssefian S
Environ Health Prev Med; 2016 Mar; 21(2):55-70. PubMed ID: 26662949
[TBL] [Abstract][Full Text] [Related]
16. Moyamoya Disease and Spectrums of RNF213 Vasculopathy.
Bang OY; Chung JW; Kim DH; Won HH; Yeon JY; Ki CS; Shin HJ; Kim JS; Hong SC; Kim DK; Koizumi A
Transl Stroke Res; 2020 Aug; 11(4):580-589. PubMed ID: 31650369
[TBL] [Abstract][Full Text] [Related]
17. Genotype-Phenotype Correlation in Long-Term Cohort of Japanese Patients with Moyamoya Disease.
Nomura S; Yamaguchi K; Akagawa H; Kawashima A; Moteki Y; Ishikawa T; Aihara Y; Saito T; Okada Y; Kawamata T
Cerebrovasc Dis; 2019; 47(3-4):105-111. PubMed ID: 30947170
[TBL] [Abstract][Full Text] [Related]
18. Rare and Low-Frequency Variants in RNF213 Confer Susceptibility to Moyamoya Syndrome Associated with Hyperthyroidism.
Nomura S; Akagawa H; Yamaguchi K; Ishikawa T; Kawashima A; Kasuya H; Mukawa M; Nariai T; Maehara T; Okada Y; Kawamata T
World Neurosurg; 2019 Jul; 127():e460-e466. PubMed ID: 30922903
[TBL] [Abstract][Full Text] [Related]
19. RNF213 rare variants in an ethnically diverse population with Moyamoya disease.
Cecchi AC; Guo D; Ren Z; Flynn K; Santos-Cortez RL; Leal SM; Wang GT; Regalado ES; Steinberg GK; Shendure J; Bamshad MJ; ; Grotta JC; Nickerson DA; Pannu H; Milewicz DM
Stroke; 2014 Nov; 45(11):3200-7. PubMed ID: 25278557
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of
Tashiro R; Fujimura M; Sakata H; Endo H; Tomata Y; Sato-Maeda M; Niizuma K; Tominaga T
Neurol Res; 2019 Sep; 41(9):811-816. PubMed ID: 31064275
[No Abstract] [Full Text] [Related]
[Next] [New Search]